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Abstract
It has been documented that the serum complement activities measured by hemolytic assay
(CH50) are decreased after storage of sera at a low temperature in some patients with chronic hep-
atitis C. However, the mechanism of this phenomenon has not been identified yet. Here, we tried
to elucidate factors involved in the cold activation of complement (CAC). To clarify what pathway
is activated in CAC, we measured complement cleavage products after cold storage of sera. C4d
increased significantly after 12 h-storage at cold temperatures in 5 CAC (+) sera compared with 5
CAC (-) (P < 0.01) and 3 control sera (P < 0.05), while Bb did not increase in any of the groups.
In order to determine whether IgG or IgG complex is necessary for CAC, 8 CAC (+) sera were in-
cubated with Protein G Sepharose gel beads, and all of them retained hemolytic activities to some
extent after cold storage. Column chromatography through Superose 6HR of CAC-positive serum
identified the fractions containing molecules that induced CAC in normal serum, which were de-
pleted by treatment with protein G Sepharose. In conclusion, CAC in hepatitis C seems to occur
via a classical or lectin pathway, and the IgG complex produced in hepatitis C virus infection may
be an important factor in inducing CAC, a common extrahepatic manifestation of hepatitis C.
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